Skip to main content
SpringerLink
Log in

Serratiopeptidase Loaded Chitosan Nanoparticles by Polyelectrolyte Complexation: In Vitro and In Vivo Evaluation

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The aim of the present study was to formulate serratiopeptidase (SER)-loaded chitosan (CS) nanoparticles for oral delivery. SER is a proteolytic enzyme which is very sensitive to change in temperature and pH. SER-loaded CS nanoparticles were fabricated by ionic gelation method using tripolyphosphate (TPP). Nanoparticles were characterized for its particle size, morphology, entrapment efficiency, loading efficiency, percent recovery, and in vitro dissolution study. SER-CS nanoparticles had a particle size in the range of 400–600 nm with polydispersity index below 0.5. SER association was up to 80 ± 4.2%. SER loading and CS/TPP mass ratio were the primary parameters having direct influence on SER-CS nanoparticles. SER-CS nanoparticles were freeze dried using trehalose (20%) as a cryoprotectant. In vitro dissolution showed initial burst followed by sustained release up to 24 h. In vivo anti-inflammatory activity was carried out in rat paw edema model. In vivo anti-inflammatory activity in rat paw edema showed prolonged anti-inflammatory effect up to 32 h relative to plain SER.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. des Rieux A, Fievez V, Garinot M, Schneider Y-J, Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 2006;116(1):1–27.

    Article  PubMed  Google Scholar 

  2. Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res. 2007;24(12):2198–206.

    Article  CAS  PubMed  Google Scholar 

  3. Fd C, Aj T, Dm C, Lq Z, Shi K. Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. J Pharm Sci. 2007;96(2):421–7.

    Article  Google Scholar 

  4. Tasset C, Barette N, Thysman S, Ketelslegers J-M, Lemoine D. Polyisobutylcyanoacrylate nanoparticles as sustained release system for calcitonin. J Control Release. 1995;33(1):23–30.

    Article  CAS  Google Scholar 

  5. Santander-Ortega MJ, Csaba N, González L, Bastos-González D, Ortega-Vinuesa JL, Alonso MJ. Protein-loaded PLGA-PEO blend nanoparticles: encapsulation, release and degradation characteristics. Colloid Polym Sci. 2010;288(2):141–50.

    Article  CAS  Google Scholar 

  6. Lin Y-H, Chang C-H, Wu Y-S, Hsu Y-M, Chiou S-F, Chen Y-J. Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti- < i > Helicobacter pylori</i > therapy. Biomaterials. 2009;30(19):3332–42.

    Article  CAS  PubMed  Google Scholar 

  7. Santander-Ortega M, Bastos-Gonzalez D, Ortega-Vinuesa J, Alonso M. Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization. J Biomed Nanotechnol. 2009;5(1):45–53.

    Article  CAS  PubMed  Google Scholar 

  8. Patel AR, Kulkarni S, Nandekar TD, Vavia PR. Evaluation of alkyl polyglucoside as an alternative surfactant in the preparation of peptide-loaded nanoparticles. J Microencapsul. 2008;25(8):531–40.

    Article  CAS  PubMed  Google Scholar 

  9. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Control Release. 2004;100(1):5–28.

    Article  CAS  PubMed  Google Scholar 

  10. Mazzone A, Catalani M, Costanzo M, Drusian A, Mandoli A, Russo S, et al. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo. J Int Med Res. 1989;18(5):379–88.

    Google Scholar 

  11. Jadav SP, Patel NH, Shah TG, Gajera MV, Trivedi HR, Shah BK. Comparison of anti-inflammatory activity of serratiopeptidase and diclofenac in albino rats. J Pharmacol Pharmacother. 2010;1(2):116.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Fereidoni M, Ahmadiani A, Semnanian S, Javan M. An accurate and simple method for measurement of paw edema. J Pharmacol Toxicol Methods. 2000;43(1):11–4.

    Article  CAS  PubMed  Google Scholar 

  13. MAEJIMA K, MIYATA K, TOMODA K. A manganese superoxide dismutase from Serratia marcescens. Agric Biol Chem. 1983;47(7):1537–43.

    Article  CAS  Google Scholar 

  14. Rinaudo M. Chitin and chitosan: properties and applications. Prog Polym Sci. 2006;31(7):603–32.

    Article  CAS  Google Scholar 

  15. Mao H-Q, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release. 2001;70(3):399–421.

    Article  CAS  PubMed  Google Scholar 

  16. Tokumitsu H, Ichikawa H, Fukumori Y. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization. Pharm Res. 1999;16(12):1830–5.

    Article  CAS  PubMed  Google Scholar 

  17. Mitra S, Gaur U, Ghosh P, Maitra A. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release. 2001;74(1):317–23.

    Article  CAS  PubMed  Google Scholar 

  18. Calvo P, Remunan-Lopez C, Vila-Jato J, Alonso M. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci. 1997;63(1):125–32.

    Article  CAS  Google Scholar 

  19. Gan Q, Wang T. Chitosan nanoparticle as protein delivery carrier—systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B: Biointerfaces. 2007;59(1):24–34.

    Article  CAS  PubMed  Google Scholar 

  20. Aktaş Y, Andrieux K, Alonso MJ, Calvo P, Gürsoy RN, Couvreur P, et al. Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor. Int J Pharm. 2005;298(2):378–83.

    Article  PubMed  Google Scholar 

  21. Katas H, Alpar HO. Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release. 2006;115(2):216–25.

    Article  CAS  PubMed  Google Scholar 

  22. Rudzinski WE, Aminabhavi TM. Chitosan as a carrier for targeted delivery of small interfering RNA. Int J Pharm. 2010;399(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  23. Gan Q, Wang T, Cochrane C, McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan—TPP nanoparticles intended for gene delivery. Colloids Surf B: Biointerfaces. 2005;44(2):65–73.

    Article  CAS  PubMed  Google Scholar 

  24. Csaba N, Köping-Höggård M, Alonso MJ. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. Int J Pharm. 2009;382(1):205–14.

    Article  CAS  PubMed  Google Scholar 

  25. Kumbhar D, Wavikar P, Vavia P. Niosomal Gel of Lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity. AAPS PharmSciTech. 2013;14(3):1072–82.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Crystalline KM, Desoxyribonuclease I. Isolation and general properties spectrophotometric method for the measurement of desoxyribonuclease activity. J Gen Physiol. 1950;33(4):349–62.

    Article  Google Scholar 

  27. Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58(15):1688–713.

    Article  CAS  PubMed  Google Scholar 

  28. Date PV, Samad A, Devarajan PV. Freeze thaw: a simple approach for prediction of optimal cryoprotectant for freeze drying. AAPS PharmSciTech. 2010;11(1):304–13.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

The authors want to acknowledge DBT and UGC for fellowship and AICTE/NAFETIC and Kusum HealthCare for proving laboratory facilities.

Conflict of Interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga (E), 400019, Mumbai, India

    Nitin Mali, Preeti Wavikar & Pradeep Vavia

  2. Center for Novel Drug Delivery Systems, Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, N. P. Marg, Matunga (E), Mumbai, 400 019, India

    Pradeep Vavia

Authors
  1. Nitin Mali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Preeti Wavikar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pradeep Vavia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pradeep Vavia.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mali, N., Wavikar, P. & Vavia, P. Serratiopeptidase Loaded Chitosan Nanoparticles by Polyelectrolyte Complexation: In Vitro and In Vivo Evaluation. AAPS PharmSciTech 16, 59–66 (2015). https://doi.org/10.1208/s12249-014-0201-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-014-0201-0

KEY WORDS

Search

Navigation